Clinical Trials · NCT02572323
Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of California, San Diego
- Enrollment
- 73
- Start date
- Feb 2017
- Locations
- 4 sites, United States
- Primary endpoint
- Change in Neurocognitive Performance